STEPHEN GEORGE DILLY
CIK 1389147 · See Remarks · last filed 2025-11-12
STEPHEN GEORGE DILLY is a corporate insider who has filed 47 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider was granted $92.4K of CDXS on Nov 12, 2025. Across all open-market trades the lifetime net is −$21.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.57M
6
47
-$21.65M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | See Remarks | 727,053 | $2.40 | $1.74M | -$151.3K | 10 | 2025-11-12 |
| Sierra Oncology, Inc. (SRRA) Delisted | CEO and President | 0 | $54.99 | $0 | $89.1K | 7 | 2022-07-01 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 15,000 | $0.18 | $2.7K | -$300.3K | 13 | 2020-06-03 |
| COLL | President and CEO | 370,297 | $34.64 | $12.83M | -$21.29M | 12 | 2018-06-13 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | See Remarks | 831,158 | — | — | $0 | 1 | 2016-02-26 |
| AVIGEN INC \DE (AVGN) Delisted | Director | — | — | — | $0 | 4 | 2009-12-21 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-12 | CDXS | Grant (A) | +50,000 | $92.4K | EDGAR |
| 2025-02-07 | CDXS | Grant (A) | +88,750 | $0 | EDGAR |
| 2024-01-02 | CDXS | Grant (A) | +143,425 | $0 | EDGAR |
| 2023-09-12 | CDXS | Buy (P) | +58,479 | $101.0K | EDGAR |
| 2023-03-09 | CDXS | Mixed | +233,925 | -$252.2K | EDGAR |
| 2023-02-21 | CDXS | Grant (A) | +112,500 | $0 | EDGAR |
| 2022-08-03 | CDXS | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | −5,000 | -$275.0K | EDGAR |
| 2022-06-17 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | CDXS | Grant (A) | +11,273 | $0 | EDGAR |